Jump to content

Issac Newton

Weekend Thread - 3/10-12 | Weekend Estimates: Scream VI 44.5 (franchise best!), Creed III 27.2, LXV 12.3 #AintManIII 7, Cocaine Bear I 6.2

Recommended Posts













3 minutes ago, John Marston said:

Less than 40m is weak after the huge marketing campaign 

 

Imo, if a franchise movie (a 6th movie in a horror series especially) is about to set a new record for its franchise, i dont think it can be called weak.

  • Like 8
Link to comment
Share on other sites

Awful number and the indication of dying theater industry.

 

Just kidding. Fine for a franchise that has no real reason to be expanding audience much.

Edited by Cmasterclay
  • Like 1
Link to comment
Share on other sites







Creed III ended its first week at $74.1M at 4,007 theaters. The movie had the Imax screens this past week, which Paramount won’t have for Scream VI, though the horror pic will have the premium large format screens. Creed III made $3M yesterday, -11% from Wednesday.

The rest of the pics were as follows off industry estimates:

2. Cocaine Bear (Uni) 3,571 theaters, Thu $840K (-12% from Wed), $15.2M week, $45.4M/Wk 2

3. Ant-Man…Quantumania (Dis) 3,825 theaters, Thu $775K, -11%, $16.6M week, $190.9M/Wk 3

4. Jesus Revolution (LG) 2,575 theaters, Thu $770K (-15%), $12.3M week, $34.2M/Wk 2

5. Demon Slayer…(Cru) 1,780 theaters, Thu 1,780 theaters, Thu $452K, -21%, week $12.5M/Wk 1.

  • Like 2
Link to comment
Share on other sites









24 minutes ago, Brainbug said:

 

Imo, if a franchise movie (a 6th movie in a horror series especially) is about to set a new record for its franchise, i dont think it can be called weak.

But they spent a lot on it (when they say 35M, its really means 50M+) and marketed it like it was Top Gun 2. Still a very good result, but good to look at things in perspective. 

 

 

  • ...wtf 3
Link to comment
Share on other sites





  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use and Guidelines. Feel free to read our Privacy Policy as well.